MASI Stock Analysis: Buy, Sell, or Hold?
MASI - Masimo Corporation
$137.33
1.08 (0.79%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When MASI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MASI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MASI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$177.86
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$110.44
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MASI is currently trading at $137.33, which is considered fair relative to its 30-day fair value range of $131.96 to $141.14. The stock's valuation (Forward PE: 23.1) is in line with its historical norms (23.5). Remarkably, the market is currently pricing in an annual earnings decline of 0.6% over the next few years. This pessimistic expectation contrasts with the company's recent 214.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, MASI is in a downtrend. The price is currently testing key support at $134.45. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $183.75 (+34.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MASI is in a downtrend. The price is currently testing key support at $134.45. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $183.75 (+34.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$131.96 -
$141.14
Company Quality Score
54/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
53.8%
Protect Your Profits
Holding MASI? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.9% below Wall St target ($183.75)
Fair Price Analysis
30-Day Fair Range
$131.96 -
$141.14
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$7.61
(5.5%)
Support & Resistance Levels
Support Level
$134.45
Resistance Level
$148.76
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
23.08
Wall Street Target
$183.75
(+34.9%)
Revenue Growth (YoY)
8.2%
Earnings Growth (YoY)
214.4%
Profit Margin
-26.1%
Valuation Discount vs History
-0.6% cheaper
PE vs Historical
23.1 vs 23.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.6%
(market-implied from PE analysis)
1-Year Target
$135.43
(-1%)
2-Year Target
$134.62
(-1%)
3-Year Target
$133.81
(-2%)
3-Yr Target (if PE normalizes)
(PE: 23→24)
$136.24
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.1, Growth: 6.2%)
$163.05
(+20%)
Base:
(SPY PE: 22.3, Growth: 6.2%)
$157.52
(+16%)
Bear:
(PE: 19.0, Growth: 6.2%)
$133.89
(-2%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.1 to 23.5
Stabilization Target:
$138.72
(+1.8%)
PE Expansion Potential:
+1.8%
Last updated: January 30, 2026 9:40 PM ET
Data refreshes hourly during market hours. Next update: 10:40 PM
Data refreshes hourly during market hours. Next update: 10:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MASI showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Kevin Hern
SELL
2025-09-26
Michelle Brennan
BUY
100 shares
2025-08-12
William R Jellison
BUY
3000 shares
2025-08-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced MASI Option Strategies
Professional options setups generated by AI based on today's MASI price and gamma walls.
